{"id":6152,"date":"2022-05-01T06:30:00","date_gmt":"2022-05-01T06:30:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/realheart-releases-the-annual-report-for-2021\/"},"modified":"2022-05-01T06:30:00","modified_gmt":"2022-05-01T06:30:00","slug":"realheart-releases-the-annual-report-for-2021","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/realheart-releases-the-annual-report-for-2021\/","title":{"rendered":"Realheart releases the annual report for 2021"},"content":{"rendered":"
Press release 1 May, 2022<\/strong><\/div>\n

Today, Realheart publishes the mandatory annual financial report for 2021. A layout version (in English) with reports, collaborations and milestones during the year will be released in connection with the invitation to the Annual General Meeting that is scheduled for May 11, 2022.<\/span><\/span><\/span><\/span><\/p>\n

The entire annual report and the auditor's report are available on the company's website, www.realheart.se and as an appendix to this press release (in Swedish).<\/span><\/span><\/span><\/span><\/p>\n

\n

For more information please contact:<\/span><\/span><\/strong><\/span><\/p>\n

Ina Laura Perkins, CEO<\/span><\/span><\/p>\n

Phone: +46(0)70 406 49 21\u00a0<\/span><\/span><\/p>\n

E-mail: inalaura.perkins@realheart.se<\/span><\/span><\/p>\n

Certified Adviser: Svensk Kapitalmarknadsgranskning AB, Phone: +46 11 32 30\u00a0732, email:\u00a0ca@skmg.se<\/a><\/p>\n<\/div>\n

\n

Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart TAH has a unique, patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation.<\/em><\/span><\/span><\/p>\n<\/div>\n